Omnicell Inc. Stock
Omnicell Inc. Stock
We can see a decrease in the price for Omnicell Inc.. Compared to yesterday it has lost -€0.400 (-1.260%).
With 11 Buy predictions and not the single Sell prediction the community is currently very high on Omnicell Inc..
With a target price of 37 € there is a slightly positive potential of 17.83% for Omnicell Inc. compared to the current price of 31.4 €.
Pros and Cons of Omnicell Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
M***** P*******
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omnicell Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omnicell Inc. | -1.260% | 3.311% | 6.122% | 16.418% | -19.588% | -42.222% | -72.632% |
| Healthequity Inc. | 0.710% | -1.408% | 3.704% | -1.408% | -10.256% | 37.255% | 20.151% |
| Bruker Corp. | -0.530% | 1.787% | 16.110% | -0.317% | -18.987% | - | - |
| Myriad Genetics | 0.000% | 14.815% | 10.152% | -36.642% | -18.113% | -78.725% | -81.894% |
Comments
Omnicell (NASDAQ:OMCL) was upgraded by analysts at Bank of America Corporation from a "neutral" rating to a "buy" rating. They now have a $70.00 price target on the stock.
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell (NASDAQ:OMCL) had its "buy" rating reaffirmed by analysts at Benchmark Co..
Show more
Ratings data for OMCL provided by MarketBeat
Omnicell (NASDAQ:OMCL) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Show more
Ratings data for OMCL provided by MarketBeat
News
Omnicell Executive Trims Holdings in $244,000 Sale as Stock Trades Near 2025 Highs
Corey J Manley, EVP & Chief Legal/Admin Officer at Omnicell (NASDAQ:OMCL), executed an open-market sale of 6,106 shares for $243,629.40 on Dec. 3, 2025, as reported in the SEC Form 4 filing.
Why Omnicell Stock Crushed the Market Today
Healthcare tech company Omnicell (NASDAQ: OMCL) was quite the picture of health on Thursday, at least as far as its equity was concerned. An encouraging quarterly earnings report sent its shares